I924, the President, after referring to an important statement made on the subject at a previous meeting by Dr. Gordon Holmes, suggested that an enquiry into the later history of syphilitics who had been treated with arsenobenzol compounds might help to clear up the question as to whether the incidence of neuro-syphilis in these had in fact been greater than in syphilitic patients treated by older methods. Colonel Harrison said that during the War approximately IOO,OOO syphilitic patients had been treated in Army hospitals. That the War had commenced nearly ten years and had ended over five years ago, so that we were now in a period when we might expect the later effects of syphilis on the central nervous system to be declaring themselves. That we know approximately what percentage of neuro-syphilis we might have expected from the older forms of treatment, and that with this might be compared the incidence of clinically manifest neuro-syphilis in ex-soldiers who had been treated for syphilis in Army hospitals during the War. For At one of the treatment centres which replied to the questionnaire i68 cases with clinical signs of neurosyphilis, including I23 tabes, twelve general paresis and six tabo-paresis had been treated and their records scrutinised, with the result that cases (2) to (7) above were discovered.
One correspondent stated that the number of cases he had now seen was large, but did not supply details.
So far as they go, the results do not indicate a greater incidence of clinically manifest neuro-syphilis amongst patients who have been treated with arsenobenzol. Indeed, if those cases of syphilis are excluded in which the arsenobenzol treatment was much slighter than syphiliologists agree to be necessary, the enquiry has discovered surprisingly few instances of neuro-recurrence following the course of arsenobenzol and mercurial injections usually administered to syphilitic soldiers during the War. 
